Nalu Medical announced today that the FDA cleared expanded labeling of its peripheral nerve system to include whole-body MRI ...

NeurAxis has secured medical policy coverage for its IB-Stim technology with Molina Healthcare, expanding access to its treatment for 5.1 million members across multiple states. The coverage marks ...

("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, ...